I am responsible for the co-ordination of a portfolio of clinical studies performed within the Translational and Clinical Research Institute at the John Walton Muscular Dystrophy Research Centre. 

My role includes among others early stage engagement in study set up, preparation of protocols, generation of ethics and HRA submissions, dissemination of information about studies, upkeep of diagnostic and research databases and assistance with recruitment into and conduct of clinical trials and natural history studies. 

I am involved in the collation and management of regulatory documentation to ensure the team is conducting research in accordance with UK regulations and local guidance.

• Verhaart IEC, Robertson A, Leary R, McMacken G, Konig K, Kirschner J, Jones CC, Cook SF, Lochmuller H. A multi-source approach to determine SMA incidence and research ready population. Journal of Neurology 2017, 264(7), 1465-1473.
• Verhaart IEC, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC, Cook SF, Lochmuller H. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - A literature review. Orphanet Journal of Rare Diseases 2017, 12(1).
• Murphy LB, Schreiber-Katz O, Rafferty K, Robertson A, Topf A, Willis TA, Heidemann M, Thiele S, Bindoff L, Laurent J-P, Lochmuller H, Mathews K, Mitchell C, Stevenson JH, Vissing J, Woods L, Walter MC, Straub V. Global FKRP Registry: observations in more than 300 patients with Limb Girdle Muscular Dystrophy R9. Annals of Clinical and Translational Neurology 2020, 7(5), 757-766.